IDEXX outlines 2026 revenue of $4.741B-$4.767B and EPS of $14.96-$15.16 as CoVet adds about $5M (NASDAQ:IDXX)
· seekingalpha.com
IDEXX Q3 2026 earnings: raised revenue and EPS outlook, strong diagnostics growth, and CoVet AI expansion.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...